SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000895345-24-000018
Filing Date
2024-01-25
Accepted
2024-01-25 16:31:12
Documents
1
Group Members
AARON I. DAVISBOXER ASSET MANAGEMENT INC.BRASLYN LTD.CHRISTOPHER FUGLESANGJOE LEWISLOCKEND FIVE, LLCMVA INVESTORS, LLCSHEHAN B. DISSANAYAKE

Document Format Files

Seq Description Document Type Size
1 ff2952847_13da19-mirati.htm SC 13D/A 352433
  Complete submission text file 0000895345-24-000018.txt   354233
Mailing Address 12860 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 12860 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 400-3112
Boxer Capital, LLC (Filed by) CIK: 0001465837 (see all company filings)

IRS No.: 203828456 | State of Incorp.: DE
Type: SC 13D/A

Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Subject) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87670 | Film No.: 24562611
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)